Broker Check

Conestoga Mid Cap Fund

The lead portfolio managers of the Conestoga Mid Cap Fund are Derek Johnston and Ted Chang, and Robert Mitchell serves as co-portfolio manager.  The Fund was launched on June 29, 2021.
Investment Objective: The Fund seeks to provide long-term growth of capital.    

Fund Direct Account Access

​​To open a new Conestoga Fund Account or to view an Existing Fund Direct Account, please access the secure site above.  To open an account or for operational questions, please call the Fund's Servicing Agent (Ultimus Fund Distributors, LLC) at: (800) 494-2755.  Please contact a member of our Shareholder Services department at 1-800-494-2755 with any questions. Representatives are available Monday through Friday, 8:00am - 6:00pm EST.  You may also refer to the Fund's Prospectus and Applications below to assist in buying, exchanging and redeeming shares of each class of the Conestoga Mid Cap Fund. 



Net Assets (8/31/21)


Minimum Initial Investment

Total Gross Operation Expenses

Total Net Operation Expenses*

Investor Class



$0.6 Mil





Institutional Class



$1.1 Mil





* These are expenses that you pay each year as a percentage of the value of your investments.  Conestoga Capital Advisors, LLC (the “Adviser”) has contractually agreed to limit the Fund’s ‘Total Annual Fund Operating Expenses’ to 0.80% (for the Institutional Class) and 1.05% (for the Investors Class) of the Fund’s average daily net assets until at least June 30, 2022, subject to termination at any time at the option of the Fund. There is no guarantee that the agreement to limit the Fund's net annual operating expense will be renewed or extended.

Characteristics as of 8/31/21*

Price/Earnings (1 Yr. Fwd. incl. Neg.)42.1x
Earnings Growth (3-5 Yr. Est.)19.8%
PEG Ratio2.13
Weighted Avg. Market Cap.$28,095 Mil
ROE (Last 5 Yr. Weighted Avg.)23.3%
Long-Term Debt/Capital27.7%
Number of Holdings36

*Subject to change.

Top Ten Holdings as of 8/31/21*

1.  West Pharmaceutical Services, Inc.5.76%
2.  Copart, Inc.5.08%
3.  Fortinet, Inc.4.11%
4.  Align Technology, Inc.3.82%
5.  Bio-Techne Corp.3.68%
6.  Costar Group, Inc.3.58%
7.  Ansys, Inc.3.42%
8.  Pool Corp.3.36%
9.  Idexx Labs, Inc. 3.25%
10.Veeva Systems Inc. Cl. A3.20%

*Current and future portfolio holdings are subject to risk.

Performance as of 6/30/2021:


Russell Mid Cap Growth-0.45%

Performance as of 8/31/2021:


QTDYTD1 YearInception 6/29/2021
Russell Mid Cap Growth4.29%15.18%N/A15.18%

* All periods greater than one year are annualized.. Performance is based upon closing NAV calculation on listed dates and represents past performance. Past performance does not guarantee future results and current performance may be lower or higher than the performance quoted. Performance data includes reinvestment of dividends. Investment returns and principal value of an investment in Conestoga Mid Cap Fund will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. For the Fund’s daily NAV, list of additional holdings, total return as of the most recent month-end and a copy of the Fund’s prospectus, please visit or call 1-800-494-2755. 


Investors Share Class (CCMMX) Information

Mid Cap Fund Prospectus & Shareholder Reports

Institutional Share Class (CCMAX) Information

Additional Information